In vitro activity of aztreonam in combination with newer beta-lactams and amikacin against multiply resistant gram-negative bacilli
Authors:
- M A BuesingMBM A Buesing
- J H JorgensenJJJ H Jorgensen
- 1 February 1984
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 25 (2) , 283-285
Abstract
The in vitro synergistic activity of aztreonam in combination with piperacillin, moxalactam, cefotaxime, cefoperazone, and amikacin was examined against multiply resistant isolates of the family Enterobacteriaceae and Pseudomonas aeruginosa. Aztreonam in combination with amikacin demonstrated synergy against 71% of the isolates, whereas combinations of aztreonam plus a second beta-lactam demonstrated synergy against 42% of the isolates.Keywords
This publication has 10 references indexed in Scilit:
- Bactericidal and synergistic activity of moxalactam alone and in combination with gentamicin against Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 1983
- Synergism between aminoglycosides and cephalosporins with antipseudomonal activity: interaction index and killing curve methodAntimicrobial Agents and Chemotherapy, 1982
- Activities of various beta-lactams and aminoglycosides, alone and in combination, against isolates of Pseudomonas aeruginosa from patients with cystic fibrosisAntimicrobial Agents and Chemotherapy, 1982
- Combination of mezlocillin and azlocillin with cephalosporin antibiotics: cefoxitin, cefoperazone, cefotaxime and moxalactamJournal of Antimicrobial Chemotherapy, 1982
- Azthreonam (SQ 26,776), a synthetic monobactam specifically active against aerobic gram-negative bacteriaAntimicrobial Agents and Chemotherapy, 1982
- Comparative in vitro synergistic activity of new beta-lactam antimicrobial agents and amikacin against Pseudomonas aeruginosa and Serratia marcescensAntimicrobial Agents and Chemotherapy, 1981
- SQ 26,776, a novel -lactam: an in-vitro comparison with other antimicrobial agentsJournal of Antimicrobial Chemotherapy, 1981
- In-vitro activity of the monobactam, SQ 26,776, against Gram-negative bacteria and its stability to their -lactamasesJournal of Antimicrobial Chemotherapy, 1981
- Antimicrobial Synergism in the Therapy of Gram-Negative Rod BacteremiaChemotherapy, 1978
- Significance of antimicrobial synergism for the outcome of gram negative sepsisThe American Journal of the Medical Sciences, 1977